224 related articles for article (PubMed ID: 23333140)
1. Transcatheter aortic valve implantation with the Edwards SAPIEN versus the Medtronic CoreValve Revalving system devices: a multicenter collaborative study: the PRAGMATIC Plus Initiative (Pooled-RotterdAm-Milano-Toulouse In Collaboration).
Chieffo A; Buchanan GL; Van Mieghem NM; Tchetche D; Dumonteil N; Latib A; van der Boon RM; Vahdat O; Marcheix B; Farah B; Serruys PW; Fajadet J; Carrié D; de Jaegere PP; Colombo A
J Am Coll Cardiol; 2013 Feb; 61(8):830-6. PubMed ID: 23333140
[TBL] [Abstract][Full Text] [Related]
2. Outcomes after transcatheter aortic valve implantation with both Edwards-SAPIEN and CoreValve devices in a single center: the Milan experience.
Godino C; Maisano F; Montorfano M; Latib A; Chieffo A; Michev I; Al-Lamee R; Bande M; Mussardo M; Arioli F; Ielasi A; Cioni M; Taramasso M; Arendar I; Grimaldi A; Spagnolo P; Zangrillo A; La Canna G; Alfieri O; Colombo A
JACC Cardiovasc Interv; 2010 Nov; 3(11):1110-21. PubMed ID: 21087745
[TBL] [Abstract][Full Text] [Related]
3. Periprocedural and short-term outcomes of transfemoral transcatheter aortic valve implantation with the Sapien XT as compared with the Edwards Sapien valve.
Mussardo M; Latib A; Chieffo A; Godino C; Ielasi A; Cioni M; Takagi K; Davidavicius G; Montorfano M; Maisano F; Carlino M; Franco A; Covello RD; Spagnolo P; Grimaldi A; Alfieri O; Colombo A
JACC Cardiovasc Interv; 2011 Jul; 4(7):743-50. PubMed ID: 21777881
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes after transcatheter aortic valve replacement using valve academic research consortium definitions: a weighted meta-analysis of 3,519 patients from 16 studies.
Généreux P; Head SJ; Van Mieghem NM; Kodali S; Kirtane AJ; Xu K; Smith C; Serruys PW; Kappetein AP; Leon MB
J Am Coll Cardiol; 2012 Jun; 59(25):2317-26. PubMed ID: 22503058
[TBL] [Abstract][Full Text] [Related]
5. The role of sex on VARC outcomes following transcatheter aortic valve implantation with both Edwards SAPIEN™ and Medtronic CoreValve ReValving System® devices: the Milan registry.
Buchanan GL; Chieffo A; Montorfano M; Maisano F; Latib A; Godino C; Cioni M; Gullace MA; Franco A; Gerli C; Alfieri O; Colombo A
EuroIntervention; 2011 Sep; 7(5):556-63. PubMed ID: 21930459
[TBL] [Abstract][Full Text] [Related]
6. Procedural, 30-day and one year outcome following CoreValve or Edwards transcatheter aortic valve implantation: results of the Belgian national registry.
Bosmans JM; Kefer J; De Bruyne B; Herijgers P; Dubois C; Legrand V; Verheye S; Rodrigus I;
Interact Cardiovasc Thorac Surg; 2011 May; 12(5):762-7. PubMed ID: 21349890
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of the Edwards SAPIEN transcatheter heart valve compared with standard management and surgical aortic valve replacement in patients with severe symptomatic aortic stenosis: a Canadian perspective.
Doble B; Blackhouse G; Goeree R; Xie F
J Thorac Cardiovasc Surg; 2013 Jul; 146(1):52-60.e3. PubMed ID: 22795437
[TBL] [Abstract][Full Text] [Related]
8. Impact of aortic valve calcification on the outcome of transcatheter aortic valve implantation: results from the prospective multicenter German TAVI registry.
Staubach S; Franke J; Gerckens U; Schuler G; Zahn R; Eggebrecht H; Hambrecht R; Sack S; Richardt G; Horack M; Senges J; Steinberg DH; Ledwoch J; Fichtlscherer S; Doss M; Wunderlich N; Sievert H;
Catheter Cardiovasc Interv; 2013 Feb; 81(2):348-55. PubMed ID: 22566406
[TBL] [Abstract][Full Text] [Related]
9. One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve.
Thomas M; Schymik G; Walther T; Himbert D; Lefèvre T; Treede H; Eggebrecht H; Rubino P; Colombo A; Lange R; Schwarz RR; Wendler O
Circulation; 2011 Jul; 124(4):425-33. PubMed ID: 21747054
[TBL] [Abstract][Full Text] [Related]
10. The incidence of transcatheter aortic valve implantation-related heart block in self-expandable Medtronic CoreValve and balloon-expandable Edwards valves.
Liang M; Devlin G; Pasupati S
J Invasive Cardiol; 2012 Apr; 24(4):173-6. PubMed ID: 22477754
[TBL] [Abstract][Full Text] [Related]
11. Transcatheter aortic valve implantation: 3-year outcomes of self-expanding CoreValve prosthesis.
Ussia GP; Barbanti M; Petronio AS; Tarantini G; Ettori F; Colombo A; Violini R; Ramondo A; Santoro G; Klugmann S; Bedogni F; Maisano F; Marzocchi A; Poli A; De Carlo M; Napodano M; Fiorina C; De Marco F; Antoniucci D; de Cillis E; Capodanno D; Tamburino C;
Eur Heart J; 2012 Apr; 33(8):969-76. PubMed ID: 22240494
[TBL] [Abstract][Full Text] [Related]
12. Sex-related differences in clinical presentation and outcome of transcatheter aortic valve implantation for severe aortic stenosis.
Hayashida K; Morice MC; Chevalier B; Hovasse T; Romano M; Garot P; Farge A; Donzeau-Gouge P; Bouvier E; Cormier B; Lefèvre T
J Am Coll Cardiol; 2012 Feb; 59(6):566-71. PubMed ID: 22300690
[TBL] [Abstract][Full Text] [Related]
13. Meta-analysis of complications in aortic valve replacement: comparison of Medtronic-Corevalve, Edwards-Sapien and surgical aortic valve replacement in 8,536 patients.
Jilaihawi H; Chakravarty T; Weiss RE; Fontana GP; Forrester J; Makkar RR
Catheter Cardiovasc Interv; 2012 Jul; 80(1):128-38. PubMed ID: 22415849
[TBL] [Abstract][Full Text] [Related]
14. Early- and mid-term outcomes of transcatheter aortic valve implantation in patients with logistic EuroSCORE less than 20%: a comparative analysis between different risk strata.
Tamburino C; Barbanti M; Capodanno D; Sarkar K; Cammalleri V; Scarabelli M; Mulè M; Immè S; Aruta P; Ussia GP
Catheter Cardiovasc Interv; 2012 Jan; 79(1):132-40. PubMed ID: 21538786
[TBL] [Abstract][Full Text] [Related]
15. 2-year results of CoreValve implantation through the subclavian access: a propensity-matched comparison with the femoral access.
Petronio AS; De Carlo M; Bedogni F; Maisano F; Ettori F; Klugmann S; Poli A; Marzocchi A; Santoro G; Napodano M; Ussia GP; Giannini C; Brambilla N; Colombo A
J Am Coll Cardiol; 2012 Aug; 60(6):502-7. PubMed ID: 22726631
[TBL] [Abstract][Full Text] [Related]
16. Incidence and predictors of left bundle branch block after transcatheter aortic valve implantation.
Aktug Ö; Dohmen G; Brehmer K; Koos R; Altiok E; Deserno V; Herpertz R; Autschbach R; Marx N; Hoffmann R
Int J Cardiol; 2012 Sep; 160(1):26-30. PubMed ID: 21458085
[TBL] [Abstract][Full Text] [Related]
17. Worldwide experience with the 29-mm Edwards SAPIEN XT™ transcatheter heart valve in patients with large aortic annulus.
Wendler O; Thielmann M; Schroefel H; Rastan A; Treede H; Wahlers T; Eichinger W; Walther T
Eur J Cardiothorac Surg; 2013 Feb; 43(2):371-7. PubMed ID: 22522982
[TBL] [Abstract][Full Text] [Related]
18. Findings of a mixed transfemoral aortic valve implantation program using Edwards and CoreValve devices.
Hernández-Antolín RA; García E; Sandoval S; Almería C; Cuadrado A; Serrano J; de Obeso E; Del Valle R; Bañuelos C; Alfonso F; Guerrero F; Heredia J; Benítez JC; García-Rubira JC; Rodríguez E; Macaya C
Rev Esp Cardiol; 2011 Jan; 64(1):35-42. PubMed ID: 21190774
[TBL] [Abstract][Full Text] [Related]
19. Transcatheter aortic valve implantation (TAVI) outcome according to standardized endpoint definitions by the Valve Academic Research Consortium (VARC).
Stähli BE; Bünzli R; Grünenfelder J; Bühler I; Felix C; Bettex D; Biaggi P; Tanner FC; Nguyen-Kim DL; Plass A; Ge H; Falk V; Lüscher TF; Corti R; Maier W; Altwegg LA
J Invasive Cardiol; 2011 Aug; 23(8):307-12. PubMed ID: 21828390
[TBL] [Abstract][Full Text] [Related]
20. Prospective analysis of 30-day safety and performance of transfemoral transcatheter aortic valve implantation with Edwards SAPIEN XT versus SAPIEN prostheses.
Eltchaninoff H; Durand E; Borz B; Godin M; Tron C; Litzler PY; Bessou JP; Bejar K; Fraccaro C; Sanchez-Giron C; Dacher JN; Bauer F; Cribier A
Arch Cardiovasc Dis; 2012 Mar; 105(3):132-40. PubMed ID: 22520795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
